As demonstrated, the Stx1B-scFv OKT3 promotes up to 93% of Burkitt’s lymphoma-derived tumor cells elimination within 48 h and 90% of solid tumor cells lysis at 72 h post-treatment. Here, STX1B is linked to neoplasm.